Dark

SNGX
Soligenix, Inc. Common Stock
stock NASDAQ

At Close

Oct 28, 2025 3:59:30 PM EDT

1.56USD+0.322%(+0.01)173,462

0.00Bid 0.00Ask 0.00Spread

Pre-market

Oct 28, 2025 9:28:30 AM EDT

1.55USD-0.322%(-0.01)14,390

After-hours

Oct 28, 2025 4:35:30 PM EDT

1.56USD0.000%(0.00)1,521

OverviewHistoricalExchangesShortsMore

open chart

Market Cap

13.06M

CEO

Christopher Schaber

Headquarters

Princeton, New Jersey, USA

Industry

Biotechnology

Last Split

Jun 6, 20241for16reverse

ATHX JNJ PFE SNY EBS TEVA CBLI XLV

SNGX Stats

Avg. Vol. 10 Day

364,812

Avg. Vol. 30 Day

2,041,408

Employees

Market Cap

13,056,654

Shares Out.

8,369,650

On/Off Exchange

45%/55%

6 Month Beta

0.14

1 Year Beta

0.59

2 Year Beta

0.66

3 Year Beta

0.40

52 Week Low

1.09

52 Week High

6.23

SMA50

2.31

SMA200

2.12

1 Week

-5.74%

1 Month

+40.54%

3 Month

+21.88%

6 Month

-24.64%

1 Year

-60.61%

2 Year

-80.18%

5 Year

-99.62%

Profile

soligenix, inc. is a late stage biopharmaceutical company committed to developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense. soligenix has two areas of focus: 1) a therapeutics segment dedicated to the development of products for orphan diseases and areas of unmet medical need such as cutaneous t-cell lymphoma, oral mucositis, pediatric crohn's disease, acute radiation enteritis, and 2) a vaccines/biodefense segment to develop vaccines and therapeutics for military and civilian applications in the areas of ricin exposure, anthrax exposure, gastrointestinal acute radiation syndrome, and melioidosis.

SNGX Stock Summary

Soligenix, Inc. Common Stock (NASDAQ:SNGX) stock price today is $1.56, and today's volume is 173,462. SNGX is up 0.322% today. The 30 day average volume is 2,041,408. SNGX market cap is 13.06M with 8,369,650 shares outstanding.